Tennessee hospital using AI-assisted device for polyp detection in clinical trial

Chattanooga, Tenn.-based Erlanger Health System began a clinical trial to test an artificial intelligence device used to increase polyp detection during colonoscopy, thechattanoogan.com reported Feb. 8.

Advertisement

The health system is using a device by Magentiq Eye that uses AI software during a screening colonoscopy to identify polyps. The device is designed to complement the polyp-identification efforts of the endoscopist.

The AI software was taught to detect abnormalities after being shown thousands of images with various stages of polyp development.

Arslan Kahloon, MD, chief of gastroenterology at Erlanger, said, “We think cancers that happen between colonoscopies are due to missed polyps hiding behind the folds or flat and difficult to find polyps, so if we can find these polyps with any kind of extra detection system then we can deal with them accordingly.”

The trial is currently recruiting patients.

More articles on surgery centers:
12-OR ASC part of $295M Florida orthopedic hospital expansion
3 ASCs launching total joint programs
4 ASCs installing total joint robots

Advertisement

Next Up in GI & Endoscopy

  • Gastroenterologists are raising concerns about the CMS’ finalized payment policies, according to a joint statement from the American College of…

  • As gastroenterology evolves, leaders are reimagining how to deliver comprehensive, patient-centered care.  Dinesh Madhok, MD, CEO of Jacksonville, Fla.-based Borland…

Advertisement

Comments are closed.